Form 4 Tracker
RHYTHM PHARMACEUTICALS, INC.
RYTM

35 insider filings · Latest: Jun 23, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 14, 2025Mar 14 8:21 PMYANN MAZZABRAUD
Proposed Sale
75,000$50.24$3.8M

View →

Feb 13, 2025Feb 13 9:31 PMJENNIFER KAYDEN LEE
Proposed Sale
1,205$57.64$69.5K

View →

Feb 12, 2025Feb 12 9:42 PMJENNIFER KAYDEN LEE
Proposed Sale
1,205$57.58$69.4K

View →

Feb 10, 2025Feb 10 9:34 PMJENNIFER KAYDEN LEE
Proposed Sale
4,189$59.18$247.9K

View →

Feb 5, 2025Feb 5 9:20 PMJENNIFER KAYDEN LEE
Proposed Sale
3,066$59.95$183.8K

View →

Nov 7, 2024Nov 7 9:36 PMPAMELA CRAMER
Proposed Sale
4,688$62.65$293.7K

View →

Nov 6, 2024Nov 6 10:07 PMPAMELA CRAMER
Proposed Sale
4,687$56.25$263.6K

View →

Sep 17, 2024Sep 17 8:42 PMJENNIFER GOOD
Proposed Sale
31,751$49.52$1.6M

View →

Sep 10, 2024Sep 10 8:22 PMLYNN TETRAULT393 COMMONWEALTH AVE
Proposed Sale
17,501$50.66$886.6K

View →

Sep 9, 2024Sep 9 8:31 PMJENNIFER GOOD
Proposed Sale
16,749$49.25$824.9K

View →

Aug 26, 2024Aug 26 8:27 PMJENNIFER GOOD
Proposed Sale
35,000$46.12$1.6M

View →

Aug 26, 2024Aug 26 8:27 PMLYNN TETRAULT393 COMMONWEALTH AVE
Proposed Sale
7,499$46.12$345.9K

View →

Aug 26, 2024Aug 26 8:26 PMPAMELA CRAMER
Proposed Sale
7,299$46.12$336.6K

View →

Nov 11, 2024JOSEPH J SHULMAN
Proposed Sale
13,281$67.33$894.2K

View →

Nov 11, 2024JENNIFER KAYDEN LEE
Proposed Sale
66,861$67.33$4.5M

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 24, 2026Jun 25 10:09 PMChristophe JeanDirector
Grant/Award
6,015$107.552,324(D)

View →

Jun 23, 2026Jun 25 10:09 PMChristophe JeanDirector
Option Exercise
4,7120(D)

View →

Jun 24, 2026Jun 25 10:08 PMJ W Mcgirr DavidDirector
Grant/Award
6,015$107.552,324(D)

View →

Jun 23, 2026Jun 25 10:08 PMJ W Mcgirr DavidDirector
Option Exercise
4,7120(D)

View →

Jun 24, 2026Jun 25 10:06 PMLynn A. TetraultDirector
Grant/Award
6,015$107.552,324(D)

View →

Jun 23, 2026Jun 25 10:06 PMLynn A. TetraultDirector
Option Exercise
4,7120(D)

View →

Jun 24, 2026Jun 25 10:03 PMStuart A ArbuckleDirector
Grant/Award
6,015$107.552,324(D)

View →

Jun 23, 2026Jun 25 10:03 PMStuart A ArbuckleDirector
Option Exercise
4,7120(D)

View →

Jun 24, 2026Jun 25 10:01 PMJennifer L GoodDirector
Grant/Award
6,015$107.552,324(D)

View →

Jun 23, 2026Jun 25 10:01 PMJennifer L GoodDirector
Option Exercise
4,7120(D)

View →

Jun 22, 2026Jun 24 8:15 PMLynn A. TetraultDirector
Option Exercise
37,000$28.270(D)

View →

May 18, 2026May 20 8:15 PMHunter C SmithChief Financial Officer
Option Exercise
3,000$17.8779,000(D)

View →

May 15, 2026May 19 8:15 PMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
4,442$56.692,325(D)

View →

Apr 1, 2026Apr 3 9:36 PMYann MazabraudEVP, Head of International
Option Exercise
12,8755,000(D)

View →

Apr 1, 2026Apr 3 9:35 PMKimberly J PopovitsDirector
Grant/Award
17,065$88.1210,257(D)

View →

Mar 4, 2026Mar 6 9:51 PMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
1,500$17.973,731(D)

View →

Mar 2, 2026Mar 5 1:22 AMYann MazabraudEVP, Head of International
Grant/Award
35,000$94.9435,000(D)

View →

Mar 1, 2026Mar 4 12:45 AMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
1,1621,162(D)

View →

Mar 2, 2026Mar 3 1:56 AMHunter C SmithChief Financial Officer
Option Exercise
6,099$6.8091,401(D)

View →

Feb 14, 2026Feb 18 9:30 PMYann MazabraudEVP, Head of International
Option Exercise
10,00030,000(D)

View →

Page 1 of 2

Next →